VOR Stock Summary and Trading Ideas (Vor Biopharma | NASDAQ:VOR)

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Vor Biopharma trades on the NASDAQ stock market under the symbol VOR.

As of February 5, 2026, VOR stock price declined to $12.07 with 1,051,005 million shares trading.

VOR has a beta of 5.06, meaning it tends to be more sensitive to market movements. VOR has a correlation of 0.12 to the broad based SPY ETF.

VOR has a market cap of $501.14 million. This is considered a Small Cap stock.

In the last 3 years, VOR traded as high as $129.63 and as low as $2.62.

The top ETF exchange traded funds that VOR belongs to (by Net Assets): VTI, VXF, ITOT, IBBQ, BIB.

VOR has underperformed the market in the last year with a price return of -56.6% while the SPY ETF gained +13.8%. VOR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.3% and -33.2%, respectively, while the SPY returned +0.6% and -1.1%, respectively.

VOR support price is $11.51 and resistance is $13.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VOR shares will trade within this expected range on the day.